---
title: "GALVANI BIOELECTRONICS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/6eb6ad0b-b135-5cdc-9b8c-b2e318ca8c32
json: https://whiteintel.dev/api/public/dossier/6eb6ad0b-b135-5cdc-9b8c-b2e318ca8c32
identifier: oo:GB-COH-09984862
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GALVANI BIOELECTRONICS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-09984862`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/6eb6ad0b-b135-5cdc-9b8c-b2e318ca8c32  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/6eb6ad0b-b135-5cdc-9b8c-b2e318ca8c32  

## Ownership & control

### Owners / controllers

- **SETFIRST LIMITED** (beneficial owner) — 62.5% — https://whiteintel.dev/entity/c3d8f5a8-81f6-5054-8112-e2ec1616323f
- **Alphabet, Inc.** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/9efa4fd0-a642-44f4-8ced-c8822e2dcf06

### UBO chain (walk to the ultimate owner)

A **13-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `09984862`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2016-02-03
- **Registered office:** Gsk Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom
- **SIC:** 72190, 86900

### Officers

- [EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED](https://whiteintel.dev/entity/4401174d-4f25-5698-8e3a-3f933dd54455) — corporate secretary · appointed 2016-11-16
- COURTLAND, Calvin — director · American · appointed 2025-09-29
- GABRIEL, Kaigham Jacob, Dr — director · American · appointed 2016-11-16
- WILLIAMS, Subesh Ronald — director · British · appointed 2016-11-16
- ALTSHUL, Amy — director · American · appointed 2021-03-24 · resigned 2025-01-30
- BRIN, Sergey — director · British · appointed 2016-11-16 · resigned 2018-09-26
- CONRAD, Andrew Jason, Dr — director · American · appointed 2016-11-16 · resigned 2021-04-21
- CORSICO, Christopher, Dr — director · American · appointed 2019-02-27 · resigned 2025-03-28
- GILLETT, Stephen — director · American · appointed 2021-04-21 · resigned 2022-12-01
- HIRSCH, Bradford, Dr — director · American · appointed 2022-01-19 · resigned 2024-01-25
- MARKS, William, Dr — director · American · appointed 2022-12-01 · resigned 2023-06-16
- MEHTA, Anurag — director · American · appointed 2023-06-16 · resigned 2025-09-29
- OTIS, Brian Partick, Dr — director · American · appointed 2016-11-16 · resigned 2022-01-19
- PARRAMON, Jordi, Dr — director · Spanish,American · appointed 2018-09-26 · resigned 2023-06-16
- PODREBARAC, Theresa, Dr — director · Canadian,American · appointed 2025-04-08 · resigned 2026-03-23
- SLAOUI, Mohamed Monsif, Dr — director · Belgian · appointed 2016-11-16 · resigned 2021-03-24
- TAK, Paul-Peter, Dr — director · Dutch · appointed 2016-11-16 · resigned 2018-08-31
- TRISTER, Andrew, Dr — director · American · appointed 2023-09-27 · resigned 2026-05-01
- WALKER, Adam — director · British · appointed 2016-02-03 · resigned 2016-11-16
- [EDINBURGH PHARAMACEUTICALS INDUSTRIES LIMITED](https://whiteintel.dev/entity/4401174d-4f25-5698-8e3a-3f933dd54455) — corporate director · appointed 2016-02-03 · resigned 2016-11-16

### Beneficial owners (Persons with Significant Control)

- [Alphabet Inc.](https://whiteintel.dev/entity/9efa4fd0-a642-44f4-8ced-c8822e2dcf06) — 25–50% shares · corporate PSC · United States — since 2016-11-16
- [Setfirst Limited](https://whiteintel.dev/entity/c3d8f5a8-81f6-5054-8112-e2ec1616323f) — 50–75% shares · corporate PSC · United Kingdom — since 2016-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/09984862
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/09984862

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **GALVANI BIOELECTRONICS LIMITED** — https://whiteintel.dev/entity/6eb6ad0b-b135-5cdc-9b8c-b2e318ca8c32 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GALVANI BIOELECTRONICS LIMITED**. Human view: https://whiteintel.dev/entity/6eb6ad0b-b135-5cdc-9b8c-b2e318ca8c32 · Structured JSON: https://whiteintel.dev/api/public/dossier/6eb6ad0b-b135-5cdc-9b8c-b2e318ca8c32._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._